Mexiletine 167 mg ( DrugBank: Mexiletine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
113	筋ジストロフィー	1

113. 筋ジストロフィー

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04700046 (ClinicalTrials.gov)	July 6, 2021	5/1/2021	Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type ...	A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Investigate the Efficacy and S ...	Myotonic Dystrophy Type 1 and Type 2	Drug: Mexiletine 167 mg;Drug: Placebo	Lupin Ltd.	NULL	Not yet recruiting	18 Years	N/A	All	158	Phase 3	NULL

First Previous1Next Last